Lulu Sun

6.4k total citations · 3 hit papers
74 papers, 2.8k citations indexed

About

Lulu Sun is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Lulu Sun has authored 74 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Epidemiology. Recurrent topics in Lulu Sun's work include Liver Disease Diagnosis and Treatment (9 papers), Gut microbiota and health (8 papers) and Epigenetics and DNA Methylation (8 papers). Lulu Sun is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Gut microbiota and health (8 papers) and Epigenetics and DNA Methylation (8 papers). Lulu Sun collaborates with scholars based in China, United States and Romania. Lulu Sun's co-authors include Frank J. Gonzalez, Jie Cai, Changtao Jiang, Kristopher W. Krausz, Hong Qiao, Cen Xie, Andrew D. Patterson, Wei Kong, Shogo Takahashi and Dongxue Sun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Lulu Sun

71 papers receiving 2.7k citations

Hit Papers

Gut microbiota-derived bile acids in intestinal immunity,... 2021 2026 2022 2024 2022 2021 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lulu Sun China 25 1.5k 601 548 448 401 74 2.8k
Runping Liu China 33 1.7k 1.1× 1.2k 2.1× 623 1.1× 529 1.2× 589 1.5× 99 3.5k
Thomas Q. de Aguiar Vallim United States 24 2.2k 1.5× 635 1.1× 775 1.4× 536 1.2× 762 1.9× 42 3.8k
Hisashi Tsurumi Japan 37 1.1k 0.7× 592 1.0× 909 1.7× 412 0.9× 325 0.8× 201 3.7k
Dilip K. Deb United States 31 1.1k 0.8× 371 0.6× 567 1.0× 299 0.7× 281 0.7× 41 3.3k
Jing Gong China 31 1.0k 0.7× 302 0.5× 345 0.6× 261 0.6× 336 0.8× 101 2.9k
Chia‐Hung Yen Taiwan 32 1.5k 1.0× 367 0.6× 261 0.5× 427 1.0× 522 1.3× 140 3.5k
Francisco Javier Cubero Spain 32 937 0.6× 1.3k 2.1× 336 0.6× 323 0.7× 404 1.0× 90 2.9k
Na Liu China 37 1.9k 1.3× 335 0.6× 353 0.6× 266 0.6× 478 1.2× 134 3.8k
Wolfgang E. Thasler Germany 35 1.6k 1.1× 932 1.6× 994 1.8× 339 0.8× 903 2.3× 131 4.3k
Yang Zhang China 31 1.3k 0.9× 834 1.4× 187 0.3× 232 0.5× 328 0.8× 150 3.1k

Countries citing papers authored by Lulu Sun

Since Specialization
Citations

This map shows the geographic impact of Lulu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulu Sun more than expected).

Fields of papers citing papers by Lulu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lulu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulu Sun. The network helps show where Lulu Sun may publish in the future.

Co-authorship network of co-authors of Lulu Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lulu Sun. A scholar is included among the top collaborators of Lulu Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lulu Sun. Lulu Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Yangliu, Yang Zhang, Nana Yan, et al.. (2024). Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders. Acta Pharmaceutica Sinica B. 15(2). 892–908. 4 indexed citations
2.
Liu, Qiaoyan, et al.. (2024). Development and evaluation of a clinical nursing decision support system for the prevention of neonatal hypoglycaemia. BMC Medical Informatics and Decision Making. 24(1). 400–400. 1 indexed citations
3.
Zeng, Guangyi, Wei Guo, Bo Chen, Yanli Pang, & Lulu Sun. (2024). Smoking associated metabolites from gut microbiota on health: Nicotine degradation brings hopes. SHILAP Revista de lepidopterología. 1(3). 100036–100036.
4.
Zhang, Yi, Xuemei Wang, Jun Lin, et al.. (2024). A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH. Cell Metabolism. 36(8). 1823–1838.e6. 26 indexed citations
5.
Fu, Liezhen, Yijun Su, Zuojia Chen, et al.. (2024). Amino acid transporter SLC7A5 regulates cell proliferation and secretary cell differentiation and distribution in the mouse intestine. International Journal of Biological Sciences. 20(6). 2187–2201. 3 indexed citations
6.
Zhou, Peng, et al.. (2024). SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease. Theranostics. 14(2). 861–878. 4 indexed citations
8.
Qu, Ruize, Yi Zhang, Yanpeng Ma, et al.. (2023). Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Advanced Science. 10(23). e2205563–e2205563. 144 indexed citations breakdown →
9.
Tolbert, William D., Yaozong Chen, Lulu Sun, et al.. (2023). The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11. Frontiers in Immunology. 14. 1178355–1178355. 4 indexed citations
10.
Zhang, Xiaona, et al.. (2022). Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy. International Immunopharmacology. 110. 108820–108820. 8 indexed citations
11.
Sun, Lulu, Jie Cai, & Frank J. Gonzalez. (2021). The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Nature Reviews Gastroenterology & Hepatology. 18(5). 335–347. 288 indexed citations breakdown →
12.
Sun, Shusen, Jingkai Wei, Dandan Li, et al.. (2020). Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system. International Journal of Clinical Pharmacy. 42(5). 1364–1368. 5 indexed citations
13.
Zhang, Xingzhong, Yangming Zhang, Pengcheng Wang, et al.. (2019). Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism. Cell Metabolism. 30(5). 937–951.e5. 105 indexed citations
14.
Zhu, Qiong, et al.. (2019). Intra-clot Microbubble-Enhanced Ultrasound Accelerates Catheter-Directed Thrombolysis for Deep Vein Thrombosis: A Clinical Study. Ultrasound in Medicine & Biology. 45(9). 2427–2433. 8 indexed citations
15.
16.
Xie, Cen, Tomoki Yagai, Yuhong Luo, et al.. (2017). Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. Nature Medicine. 23(11). 1298–1308. 128 indexed citations
17.
Chang, Wei, et al.. (2017). Correlation of PICCO/CT on cardiac output index value and prognosis in patients with heart disease.. PubMed. 31(2). 465–471. 2 indexed citations
18.
Wu, Yanhui, et al.. (2016). Association of ADIPOQ variants with type 2 diabetes mellitus susceptibility in ethnic Han Chinese from northeast China. Journal of Diabetes Investigation. 7(6). 853–859. 16 indexed citations
19.
Liu, Wei, Yong Fang, Xiaotong Wang, et al.. (2014). Overcoming 5-Fu Resistance of Colon Cells through Inhibition of Glut1 by the Specific Inhibitor WZB117. Asian Pacific Journal of Cancer Prevention. 15(17). 7037–7041. 48 indexed citations
20.
Zhang, Ruifang, Yi Song, Yuanyuan Zhou, & Lulu Sun. (2013). Comparison of Aortic Annulus Diameter Measurement between Multi-Detector Computed Tomography and Echocardiography: A Meta-Analysis. PLoS ONE. 8(3). e58729–e58729. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026